These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10182699)

  • 1. Natural rubber-containing medical devices; user labeling; cold seal adhesives partial stay--FDA. Final rule.
    Fed Regist; 1998 Aug; 63(168):46174-5. PubMed ID: 10182699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural rubber-containing medical devices; user labeling--FDA. Final rule.
    Fed Regist; 1997 Sep; 62(189):51021-30. PubMed ID: 10175218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Aug; 63(168):46171-4. PubMed ID: 10182698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
    Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Jun; 63(104):29552-90. PubMed ID: 10179863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Sep; 63(183):50660-704. PubMed ID: 10185803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetrical and gynecological devices; designation of special controls for male condoms made of natural rubber latex.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Nov; 73(218):66522-39. PubMed ID: 19112703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration--FDA. Tentative final rule.
    Fed Regist; 1991 Nov; 56(228):60024-39. PubMed ID: 10115705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based approach to medication preparation for the surgical patient at risk for latex allergy: is it time to stop being stopper poppers?
    Heitz JW; Bader SO
    J Clin Anesth; 2010 Sep; 22(6):477-83. PubMed ID: 20868972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General and plastic surgery devices; classification of silicone sheeting. Final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2004 Aug; 69(152):48146-8. PubMed ID: 15300956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Aug; 69(164):52170-1. PubMed ID: 15329983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; reports of corrections and removals; lift of stay of effective date--FDA. Final rule; lift of stay of effective date.
    Fed Regist; 1998 Apr; 63(73):18836. PubMed ID: 10179315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance.
    Fed Regist; 2000 Sep; 65(190):58346-50. PubMed ID: 11503646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(202):62282-5. PubMed ID: 11503680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; exemptions from premarket notification; class II devices. Final rule.
    Food and drug Administration, HHS
    Fed Regist; 2001 Nov; 66(221):57368-9. PubMed ID: 11776279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.